Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

Yong Yu; Jingjing Qi; Jieyi Xiong; Liping Jiang; Di Cui; Junlin He; Ping Chen; Lianjie Li; Chenjie Wu; Tonghui Ma; Su Shao; Jianjun Wang; Dansong Yu; Bing Zhou; Dongsheng Huang; Clemens Schmitt; Ran Tao

doi:10.7150/thno.29520

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

Yong Yu
, Jingjing Qi
, Jieyi Xiong
, Liping Jiang
, Di Cui
, Junlin He
, Ping Chen
, Lianjie Li
, Chenjie Wu
, Tonghui Ma
, Su Shao
, Jianjun Wang
, Dansong Yu
, Bing Zhou
, Dongsheng Huang
, Clemens Schmitt
, Ran Tao

Department of Internal Medicine 3 - Hematology and Internal Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	761-777
Number of pages	17
Journal	Theranostics
Volume	9
Issue number	3
DOIs	https://doi.org/10.7150/thno.29520
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302 Clinical Medicine

Access to Document

10.7150/thno.29520

Cite this

@article{8bdaad71894c4f67913de53235e0480c,

title = "Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer",

author = "Yong Yu and Jingjing Qi and Jieyi Xiong and Liping Jiang and Di Cui and Junlin He and Ping Chen and Lianjie Li and Chenjie Wu and Tonghui Ma and Su Shao and Jianjun Wang and Dansong Yu and Bing Zhou and Dongsheng Huang and Clemens Schmitt and Ran Tao",

year = "2019",

doi = "10.7150/thno.29520",

language = "English",

volume = "9",

pages = "761--777",

journal = "Theranostics",

issn = "1838-7640",

number = "3",

}

TY - JOUR

T1 - Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

AU - Yu, Yong

AU - Qi, Jingjing

AU - Xiong, Jieyi

AU - Jiang, Liping

AU - Cui, Di

AU - He, Junlin

AU - Chen, Ping

AU - Li, Lianjie

AU - Wu, Chenjie

AU - Ma, Tonghui

AU - Shao, Su

AU - Wang, Jianjun

AU - Yu, Dansong

AU - Zhou, Bing

AU - Huang, Dongsheng

AU - Schmitt, Clemens

AU - Tao, Ran

PY - 2019

Y1 - 2019

UR - https://www.ncbi.nlm.nih.gov/pubmed/30809307

U2 - 10.7150/thno.29520

DO - 10.7150/thno.29520

M3 - Article

SN - 1838-7640

VL - 9

SP - 761

EP - 777

JO - Theranostics

JF - Theranostics

IS - 3

ER -

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this